doi:10.1007/s12250-019-00117-0

[1]
Pinghu Zhang, Shuo Zhai, Jinhong Chang, Ju-Tao Guo, 2018: In Vitro Anti-hepatitis B Virus Activity of 2', 3'-Dideoxyguanosine, Virologica Sinica, 33, 538-544. doi: 10.1007/s12250-018-0065-7
[2]
Jun Wu, Ruth Bröring, Jörg F. Schlaak, 2008: The Role of the Innate Immune System of the Liver in the Control of HBV and HCV^*, Virologica Sinica, 23, 116-123. doi: 10.1007/s12250-008-2942-y
[3]
赵文彬, 黄浦昌, 王行钵, 吴桃林, 周克捷, 张秀惠, 张元英, 林克泳, 1990: Efficacy of Treating Chronic Hepatitis B with HB Vaccine and Small Doses of Interferon and Thymosin, Virologica Sinica, 5, 379-.
[4]
黄华芳, 熊开钧, 王心禾, 曾令兰, 李嫒, 贺永文, 杨泽川, 凌美霞, 范家珍, 吴章琦, 1989: The Contrast Observation of Antiviral Effect of Interferon with Two Different Dosages in Chronic Hepatitis B, Virologica Sinica, 4, 383-.
[5]
Jie-Li Hu, Ai-Long Huang, 2024: Classifying hepatitis B therapies with insights from covalently closed circular DNA dynamics, Virologica Sinica, 39, 9-23. doi: 10.1016/j.virs.2023.12.005
[6]
田拥军, 覃莉, 张正茂, 李磊, 雷延昌, 喻植群, 赵西平, 杨东亮*, 2005: Study on a Transgenic Cell Line Stable Expression Gly145Arg Mutation HBsAg, Virologica Sinica, 20, 574-577.
[7]
Ju-sheng LIN, Lin-lin GAO, 2008: Advances in Research on Hepatitis B Virus DNA Integration, Virologica Sinica, 23, 93-99. doi: 10.1007/s12250-008-2939-6
[8]
邓卫文, 谢弘, 闻玉梅, 1997: The research of in vivo transfection of cloned duck hepatitis B virus DNA dimer, Virologica Sinica, 12, 66-.
[9]
Mengying Ji,, Kanghong Hu, 2017: Recent advances in the study of hepatitis B virus covalently closed circular DNA, Virologica Sinica, 32, 454-464. doi: 10.1007/s12250-017-4009-4
[10]
Jing Li, Yangyang Hu, Yifei Yuan, Yinan Zhao, Qiqi Han, Canyu Liu, Xue Hu, Yuan Zhou, Yun Wang, Yu Guo, Chunchen Wu, Xinwen Chen, Rongjuan Pei, 2021: Repurposing of Antazoline Hydrochloride as an Inhibitor of Hepatitis B Virus DNA Secretion, Virologica Sinica, 36, 501-509. doi: 10.1007/s12250-020-00306-2
[11]
谭维国, 李法卿, 吴玉强, 吴德福, 龚希平, 1994: Detection of HBsAgHBeAg and HBV DNA in Urinary cells of Patients with Hepatitis B an d HBsAg Carriers, Virologica Sinica, 9, 100-103.
[12]
吕冬梅, 陈尔佳, 谢天宏, 庄俊英, 刘勇, 李春宏, 孙茂盛, 戴长柏, 2001: DNA Immunization of Hepatitis E Virus(HEV), Virologica Sinica, 16, 131-134.
[13]
Min Chen, Huichao Chen, Yanling Ma, Manhong Jia, Wenfei Ding, 2026: Identification of a novel HIV-1 circulating recombinant form (CRF161_0107) from CRF01_AE-C5 lineage among men who have sex with men in southwestern China, Virologica Sinica, 41, 470-473. doi: 10.1016/j.virs.2026.03.008
[14]
Yu Chen, Deyin Guo, 2016: Molecular mechanisms of coronavirus RNA capping and methylation, Virologica Sinica, 31, 3-11. doi: 10.1007/s12250-016-3726-4
[15]
You-hua XIE, Ran HONG, Wei LIU, Jing LIU, Jian-wei ZHAI, 2010: Development of Novel Therapeutics for Chronic Hepatitis B^*, Virologica Sinica, 25, 294-300. doi: 10.1007/s12250-010-3138-9
[16]
Yin-ping LU, Bao-ju WANG, Ji-hua DONG, Zhao LIU, Shi-he GUAN, Meng-ji LU, Dong-liang YANG, 2007: Construction and Characterization of a Hepatitis B Virus Replicon, Virologica Sinica, 22, 8-13.
[17]
郭亚兵, 侯金林, 戴炜, 骆抗先, P.Karayiannis, 1999: Sequencing of the W hole Gene of Hepatitis B Virus, Virologica Sinica, 14, 205-209.
[18]
熊开钧, 黄华芳, 王心禾, 金慰鄂, 曾令兰, 杨泽川, 凌美霞, 张雪珍, 吴章琦, 1987: THE TREATMENT EFFECT OF HEPATITIS B WITH INTERFERON AND ACYCLOVIR, Virologica Sinica, 2, 17-.
[19]
熊开钧, 王心禾, 黄华芳, 姚梦林, 代家珠, 金慰鄂, 范红梅, 曾全兰, 张雪珍, 1987: THE OBSERVATION OF A TREATED RESULT WITH ACYCLOVIR IN HEPATITIS B VIRUS, Virologica Sinica, 2, 78-.
[20]
吴婷, 黄海, 1998: The Inhibitory Effects of Enduracidin on Hepatitis B Virus in vitro, Virologica Sinica, 13, 45-.